Skip to main content
GovWire

House Oversight Panel Advances Bills on IG Council, FEHB/PSHB Drug Costs, and Rulemaking

·2 min read·Source: FEDweek
Source:FEDweek

The House Oversight and Government Reform Committee advanced a package of bills that would reshape oversight of inspectors general, change how prescription drug costs are handled under FEHB and PSHB, and tighten requirements around federal rulemaking—moves that could affect agencies’ compliance workload and benefit program administration if enacted.

  • Committee action: The measures were advanced by the House Oversight and Government Reform Committee and passed on party-line votes, according to FEDweek.
  • Inspectors general: One bill would abolish the Council of the Inspectors General on Integrity and Efficiency (CIGIE), the central coordinating body for federal inspectors general, FEDweek reported.
  • FEHB/PSHB prescription drugs: Other bills would address prescription drug costs in the Federal Employees Health Benefits (FEHB) program and the Postal Service Health Benefits (PSHB) program, according to FEDweek.
  • Rulemaking: Additional legislation would affect federal rulemaking, potentially changing how agencies develop, justify, or finalize regulations, FEDweek said.
  • Next steps: None of the bills are law. Each would require approval by the full House and the Senate and then presidential action before taking effect, per FEDweek.

Brief context

The committee action comes as lawmakers continue to debate federal oversight structures, benefit program cost controls, and the scope and process of agency rulemaking. CIGIE currently serves as a governmentwide forum for inspectors general, including work on integrity, efficiency, and coordination across IG offices. Any change to that structure could shift how IGs collaborate and how cross-agency oversight priorities are set.

On the benefits side, FEHB covers most federal civilian employees and many annuitants, while PSHB is the separate program being established for eligible Postal Service employees and annuitants. Changes affecting prescription drug costs could influence plan administration and cost-sharing rules over time, depending on how the bills are written and implemented.

For employees and retirees trying to understand how policy changes can ripple into long-term finances, the most direct personal impact often shows up through total compensation and retirement planning. For estimating retirement value under current rules, readers can use the FERS retirement calculator.

Source: FEDweek

Related Topics

house-oversightlegislationinspectors-generalcigiefehbpshbprescription-drugsrulemaking